From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

from The Business of Pharmacy Podcast™ · host Mike Koelzer, Pharmacist

Can a small biotech change cancer care—and turn a profit? Paul Romness, CEO of OS Therapies, shares how his five-person team took on one of the deadliest pediatric cancers, went public, and might just shake up the system. From biologics to Wall Street, this one’s got it all. Sponsored by Dae Lee of Buchanan.

Episode metadata supplied by the publisher feed · Published May 19, 2025

Embed this episode

Attribution link and audio player

Ready to play

From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

0:00 38:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Business of Pharmacy Podcast™?

This episode is 38 minutes long.

When was this The Business of Pharmacy Podcast™ episode published?

This episode was published on May 19, 2025.

Can I download this The Business of Pharmacy Podcast™ episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!